S

Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506

Watchlist Manager
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Watchlist
Price: 286.08 CNY -1.06% Market Closed
Market Cap: 114.7B CNY

Intrinsic Value

The intrinsic value of one Sichuan Biokin Pharmaceutical Co Ltd stock under the Base Case scenario is 48.01 CNY. Compared to the current market price of 286.08 CNY, Sichuan Biokin Pharmaceutical Co Ltd is Overvalued by 83%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
48.01 CNY
Overvaluation 83%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Sichuan Biokin Pharmaceutical Co Ltd

Sichuan Biokin Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Sichuan Biokin Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Sichuan Biokin Pharmaceutical Co Ltd?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Sichuan Biokin Pharmaceutical Co Ltd’s research
View All Researches
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
CN
Pharmaceuticals
Market Cap
114.7B CNY
IPO
Jan 6, 2023
CN
Pharmaceuticals
Market Cap
114.7B CNY
IPO
Jan 6, 2023
Price
ÂĄfalse
EPS
ÂĄfalse
AI Assistant
AI Assistant
Ask me anything about Sichuan Biokin Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sichuan Biokin Pharmaceutical Co Ltd

Current Assets 6.3B
Cash & Short-Term Investments 5.8B
Receivables 255m
Other Current Assets 299.1m
Non-Current Assets 830.2m
Long-Term Investments 1.3m
PP&E 573.1m
Intangibles 26.7m
Other Non-Current Assets 229m
Efficiency

Free Cash Flow Analysis
Sichuan Biokin Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sichuan Biokin Pharmaceutical Co Ltd

Revenue
5.8B CNY
Cost of Revenue
-283.8m CNY
Gross Profit
5.5B CNY
Operating Expenses
-1.8B CNY
Operating Income
3.7B CNY
Other Expenses
-13.3m CNY
Net Income
3.7B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sichuan Biokin Pharmaceutical Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional ROE
Exceptional ROIC
47/100
Profitability
Score

Sichuan Biokin Pharmaceutical Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sichuan Biokin Pharmaceutical Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
76/100
Solvency
Score

Sichuan Biokin Pharmaceutical Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sichuan Biokin Pharmaceutical Co Ltd

Wall Street analysts forecast Sichuan Biokin Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sichuan Biokin Pharmaceutical Co Ltd is 310.58 CNY with a low forecast of 302.39 CNY and a high forecast of 330.4 CNY.

Lowest
Price Target
302.39 CNY
6% Upside
Average
Price Target
310.58 CNY
9% Upside
Highest
Price Target
330.4 CNY
15% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Sichuan Biokin Pharmaceutical Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Sichuan Biokin Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Sichuan Biokin Pharmaceutical Co Ltd stock?

The intrinsic value of one Sichuan Biokin Pharmaceutical Co Ltd stock under the Base Case scenario is 48.01 CNY.

Is Sichuan Biokin Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 286.08 CNY, Sichuan Biokin Pharmaceutical Co Ltd is Overvalued by 83%.

Back to Top